当前位置:首页 - 行情中心 - 康辰药业(603590) - 财务分析

康辰药业

(603590)

  

流通市值:53.78亿  总市值:54.05亿
流通股本:1.58亿   总股本:1.59亿

康辰药业(603590)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2026年第一季度实现净利润0.49亿元,每股收益0.30元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2026年第一季度最新股东权益350776.64万元,未分配利润208242.64万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2026年第一季度最新总资产407717.60万元,负债56940.96万元。

利润表
报告期2026-03-312025-12-312025-09-302025-06-30
营业总收入214,870,397.3915,123,690.39692,220,405.14460,869,253.77
营业总成本156,475,838.57724,859,248.04534,795,468.49340,875,691.38
其他经营收益
营业利润60,552,430.3203,016,640.4161,262,569.23121,192,249.93
利润总额58,702,330.35189,686,430.81148,211,291.92109,767,887.26
净利润48,512,063.09169,423,424.87134,302,584.9996,334,639.19
每股收益
其他综合收益4,785,418.36-10,653,418.31-48,898,274.85-44,025,848.89
综合收益总额53,297,481.45158,770,006.5685,404,310.1452,308,790.3
资产负债表
报告期2026-03-312025-12-312025-09-302025-06-30
流动资产:
流动资产合计1,322,653,489.811,395,528,838.131,351,700,571.171,377,549,887.35
非流动资产:
非流动资产合计2,754,522,521.092,699,466,329.562,696,856,164.32,494,265,812.38
资产总计4,077,176,010.94,094,995,167.694,048,556,735.473,871,815,699.73
流动负债:
流动负债合计433,812,505.06459,447,457.05433,030,825.67333,523,462.39
非流动负债:
非流动负债合计135,597,066.34139,063,293.77130,399,732.97132,480,066.11
负债合计569,409,571.4598,510,750.82563,430,558.64466,003,528.5
所有者权益(或股东权益):
归属于母公司股东权益合计3,221,259,791.283,211,276,257.443,196,951,992.493,118,771,943.97
股东权益合计3,507,766,439.53,496,484,416.873,485,126,176.833,405,812,171.23
负债和股东权益合计4,077,176,010.94,094,995,167.694,048,556,735.473,871,815,699.73
现金流量表
报告期2026-03-312025-12-312025-09-302025-06-30
经营活动产生的现金流量:
经营活动现金流入小计244,911,400.88992,029,766.77706,019,570.76407,103,252.66
经营活动现金流出小计224,314,436.42876,351,418.68622,120,320.66418,780,386.38
经营活动产生的现金流量净额20,596,964.46115,678,348.0983,899,250.1-11,677,133.72
投资活动产生的现金流量:
投资活动现金流入小计517,833,367.21,213,447,484.341,014,041,071.43831,574,895.41
投资活动现金流出小计478,961,190.41,169,155,297.35945,353,149.48587,583,874.14
投资活动产生的现金流量净额38,872,176.844,292,186.9968,687,921.95243,991,021.27
筹资活动产生的现金流量:
筹资活动现金流入小计43,974,915298,867,756.47256,505,696.4784,705,761.62
筹资活动现金流出小计78,570,025.44316,216,372.88291,205,997.07140,690,367.37
筹资活动产生的现金流量净额-34,595,110.44-17,348,616.41-34,700,300.6-55,984,605.75
汇率变动对现金及现金等价物的影响-84,904.01-26,524.81-1,701.257,729.74
现金及现金等价物净增加额24,789,126.81142,595,393.86117,885,170.2176,337,011.54
期末现金及现金等价物余额357,362,222.51332,573,095.7307,862,872.04366,314,713.38
补充资料:
现金及现金等价物的净增加额-142,595,393.86-176,337,011.54
最新报告期:2026-05-05
研究机构分析师预测每股收益(元)更新日
2026年2027年2028年
长江证券刘长洪,彭英骐1.161.372.082026-05-05
中银证券刘恩阳1.201.301.402026-04-29
太平洋张懿,谭紫媚1.081.231.582026-04-28
东方证券伍云飞,傅肖依1.161.441.822026-04-28
首创证券王斌1.221.461.762026-04-27
TOP↑